SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615774-18-001760
Filing Date
2018-03-09
Accepted
2018-03-09 16:01:41
Documents
1
Period of Report
2018-03-07

Document Format Files

Seq Description Document Type Size
1 4 s109293_form4.html 4  
1 4 s109293_form4.xml 4 4486
  Complete submission text file 0001615774-18-001760.txt   6074
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Issuer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 650 688 0822
Vivo Capital VIII, LLC (Reporting) CIK: 0001618789 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37411 | Film No.: 18680050